Author:
Blondel-Hill E.,Hetchler C.,Andrews D.,Lapointe L.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference51 articles.
1. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing;Barenfanger;J Clin Microbiol,1999
2. Clinical impact of rapid in vitro susceptibility testing and bacterial identification;Doern;J Clin Microbiol,1994
3. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes;Lautenbach;Clin Infect Dis,2001
4. Outcomes assessment measuring clinical and financial impact of microbiologic based protocols: C) Comparing antimicrobial susceptibility reporting [abstract C-358];Thomas,2000
5. Susceptibility testing of bacteria and fungi. Report from the Norwegian Working Group on Antibiotics;Bergan;Scand J Infect Dis,1997
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献